Advertisement

Topics

FDA gives orphan status to J&J's pediatric drug for C. diff infection

05:00 EDT 10 Aug 2017 | SmartBrief

Johnson & Johnson's cadazolid, for the treatment of pediatric patients with Clostridium difficile infection, has been granted -More

Original Article: FDA gives orphan status to J&J's pediatric drug for C. diff infection

NEXT ARTICLE

More From BioPortfolio on "FDA gives orphan status to J&J's pediatric drug for C. diff infection"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Clostridium difficile (CDI)
A clostridium difficile infection (CDI) is a type of bacterial infection that can affect the digestive system. It most commonly affects people who are staying in hospital.  The symptoms of CDI can range from mild to severe and include: diarrhoe...